Contact PD/PI: Kimberly, Robert P The vision of the Center for Clinical and Translational Science (CCTS) Hub is to reduce health disparities in diseases disproportionately represented within the Deep South as we accelerate discovery to improve human health. We have established a robust Partner Network ? spanning Alabama, Mississippi and Louisiana ? to ensure that our research and training efforts serve the special populations in our region while maximizing collaborative synergies in translational research (Aim 1). We promote the continued development of a diverse, multidisciplinary research workforce representing all career stages, by supporting a broad portfolio of NRSA training, mentored career development, content specific educational programs and experiential learning opportunities (Aim 2). These initiatives deepen scientific understanding of clinical and translational science, establish core competencies and advance the knowledge base in good clinical practice, study design, bioethics, conduct of clinical trials and team science. The CCTS supports ethical, scientifically rigorous clinical trials and pilot research across the CCTS Partner Network (Aim 3) through focused efforts to provide resources, specialized services and consultation in genomics, informatics, biostatistics and epidemiology, clinical research, advanced imaging and drug discovery. The CCTS fosters the application of best practices, including those established by the CTSA Consortium, and will promote tools that enable the rapid and efficient execution of multi-site clinical trials, taking advantage of the electronic health record to inform feasibility and access to study populations. Importantly, in keeping with our goal of reducing regional health disparities, we recognize the importance of engaging our communities in the planning and conduct of research (Aim 4). Through our community engagement arm ? One Great Community ? we are expanding programmatic outreach by taking successful community-based participatory research approaches to a regional scale. Finally, we understand the importance of evaluating the activities of the CCTS Partner Network to ensure that we are accomplishing our goals (Aim 5). Didactic programs, community engagement and research processes are evaluated by a panel of tailored and common metrics to guide strategies and outline progress towards achieving defined goals. By achieving these aims, the CCTS Partner Network will accelerate clinical and translational research in the Deep South and advance the amelioration the significant health disparities faced by our populations. Further, the CCTS Hub and its Partner Network will be well-positioned to work with other hubs and the CTSA Consortium in the dissemination of best practices in clinical and translational research and training. Project Summary/Abstract Page 248 Contact PD/PI: Kimberly, Robert P

Public Health Relevance

The UAB Center for Clinical and Translational Science (CCTS) and its regional Partner Network of ten institutions in the Deep South are dedicated to lessening health disparities and the disproportionate burden of disease in our population. We will accomplish these goals by supporting cutting-edge translational research, pursuing novel team science-driven investigation into new therapies and health care delivery paradigms, and developing the next generation of a diverse, highly-trained clinical and translational research workforce to tackle health challenges. Our work will complement and inform national and international translational research efforts to improve public health and well-being. Project Narrative Page 249

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
1UL1TR001417-01
Application #
9085533
Study Section
Special Emphasis Panel (ZTR1-SRC (99))
Program Officer
Talbot, Bernard
Project Start
2015-08-18
Project End
2019-03-31
Budget Start
2015-08-18
Budget End
2016-03-31
Support Year
1
Fiscal Year
2015
Total Cost
$7,137,348
Indirect Cost
$1,928,547
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Moore, Justin Xavier; Akinyemiju, Tomi; Bartolucci, Alfred et al. (2018) Mediating Effects of Frailty Indicators on the Risk of Sepsis After Cancer. J Intensive Care Med :885066618779941
Meredith, Ruby F; Torgue, Julien J; Rozgaja, Tania A et al. (2018) Safety and Outcome Measures of First-in-Human Intraperitoneal ? Radioimmunotherapy With 212Pb-TCMC-Trastuzumab. Am J Clin Oncol 41:716-721
Sutton, Elizabeth F; Beyl, Robbie; Early, Kate S et al. (2018) Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metab 27:1212-1221.e3
Poore, T Spencer; Virella-Lowell, Isabel; Guimbellot, Jennifer S (2018) Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis. Pediatr Pulmonol 53:E21-E23
Hsu, Joann; Donnelly, John P; Chaudhary, Ninad S et al. (2018) Aspirin use and long-term rates of sepsis: A population-based cohort study. PLoS One 13:e0194829
Pepin, Mark E; Ha, Chae-Myeong; Crossman, David K et al. (2018) Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure. Lab Invest :
Poggiogalle, Eleonora; Jamshed, Humaira; Peterson, Courtney M (2018) Circadian regulation of glucose, lipid, and energy metabolism in humans. Metabolism 84:11-27
Thompson, Kathryn A; Bulls, Hailey W; Sibille, Kimberly T et al. (2018) Optimism and Psychological Resilience are Beneficially Associated With Measures of Clinical and Experimental Pain in Adults With or at Risk for Knee Osteoarthritis. Clin J Pain 34:1164-1172
Yu, Alan S L; Shen, Chengli; Landsittel, Douglas P et al. (2018) Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease. Kidney Int 93:691-699
Heltshe, Sonya L; Rowe, Steven M; Skalland, Michelle et al. (2018) Ivacaftor-treated Patients with Cystic Fibrosis Derive Long-Term Benefit Despite No Short-Term Clinical Improvement. Am J Respir Crit Care Med 197:1483-1486

Showing the most recent 10 out of 355 publications